Having navigated the complex waters of healthcare for over three decades, I have witnessed a multitude of attempts to reform what many perceive as a flawed healthcare delivery system. My experiences have spanned various roles and responsibilities, including significant engagement with Catholic Healthcare Partners—now known as Mercy Health—in Ohio. It was during my tenure alongside
Health
The National Institutes of Health (NIH) has recently made headlines due to serious allegations of research misconduct involving Dr. Eliezer Masliah, MD, the former head of the National Institute on Aging’s (NIA) neuroscience division. The investigation, initially sparked by complaints from the Department of Health and Human Services (HHS) Office of Research Integrity (ORI), unveiled
Hemophilia B, a genetic disorder characterized by deficient levels of clotting factor IX, has traditionally required patients to adhere to a rigorous regimen of intravenous treatments to manage bleeding episodes. The paradigm for treatment has dramatically shifted with advances in gene therapy, particularly illustrated by the pivotal BENEGENE-2 trial involving fidanacogene elaparvovec (brand name Beqvez).
The expansion of Medicaid, particularly following the Affordable Care Act, has been heralded as a major step toward improving healthcare access for low-income individuals. While many studies discuss overarching trends in health outcomes post-Medicaid enrollment, a recent analysis stemming from the Oregon Health Insurance Experiment indicates that the relationship between Medicaid and specific health improvements—such
In recent events that have shaken the heart of Lebanon, the tragedy of eye injuries resulting from explosive devices used by the Hezbollah militant group highlights the grim consequences of ongoing conflict. Dr. Elias Jaradeh, an ophthalmologist, has been at the forefront of this crisis, working tirelessly in the face of overwhelming challenges. His experience
The summer of 2016 serves as a poignant chapter in my journey through pharmacy school. As a student intern, the daily grind began before dawn at 7:45 a.m., culminating after the pharmacy doors closed at 9 p.m. This grueling routine translated to shifts upwards of 13 hours, predominately spent on my feet—an exhausting norm shared
Recent research has unveiled a concerning trend in the treatment of relapsing multiple sclerosis (MS) that underscores the intersection of gender and healthcare. Data from a French registry comprising over 22,000 relapsing MS patients revealed that women are significantly less likely than men to receive appropriate treatment options, particularly disease-modifying treatments (DMTs). This disparity raises
On a pivotal front in the ongoing battle against rising healthcare costs, the Federal Trade Commission (FTC) has initiated legal proceedings against three dominant pharmacy benefit managers (PBMs): Caremark, Express Scripts, and OptumRx. These corporations, which manage approximately 80% of the prescriptions dispensed across the United States, are accused of employing anticompetitive practices leading to
The prospect of another Trump administration has stirred various discussions about its potential implications on public health, particularly concerning the influence of prominent figures like Robert F. Kennedy Jr. Known for his skepticism towards vaccines, Kennedy’s growing involvement in health leadership roles raises pressing questions about the future direction of U.S. health policy. The State
Recent findings from the U.K. Biobank have emphasized a fascinating association between moderate coffee consumption and a reduced risk of cardiometabolic multimorbidity. Analysis indicates that individuals who consume caffeine at moderate levels—typically defined as 200 to 300 mg per day—may lower their chances of developing various interconnected health conditions, such as diabetes, hypertension, and heart